Clinical Trial Update: Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of liraglutide in patients with type 2 diabetes and lower extremity arterial disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Vascular Disorder Due to Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Type 2 Diabetes, Peripheral Vascular Disorder Due to Diabetes Mellitus | Phase 4 | Status: UNKNOWN